 |
Journal articles
Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine.
Abstract : BACKGROUND: Serogroup B meningococcal (MenB) isolates currently account for approximately 90% of invasive meningococcal disease (IMD) in Greece with ST-162 clonal complex predominating. The potential of a multicomponent meningococcal B vaccine (4CMenB) recently licensed in Europe was investigated in order to find whether the aforementioned vaccine will cover the MenB strains circulating in Greece. A panel of 148 serogroup B invasive meningococcal strains was characterized by multilocus sequence typing (MLST) and PorA subtyping. Vaccine components were typed by sequencing for factor H-binding protein (fHbp), Neisserial Heparin Binding Antigen (NHBA) and Neisseria adhesin A (NadA). Their expression was explored by Meningococcal Antigen Typing System (MATS). RESULTS: Global strain coverage predicted by MATS was 89.2% (95% CI 63.5%-98.6%) with 44.6%, 38.5% and 6.1% of strains covered by one, two and three vaccine antigens respectively. NHBA was the antigen responsible for the highest coverage (78.4%), followed by fHbp (52.7%), PorA (8.1%) and NadA (0.7%). The coverage of the major genotypes did not differ significantly. The most prevalent MLST genotype was the ST-162 clonal complex , accounting for 44.6% of the strains in the panel and with a predicted coverage of 86.4%, mainly due to NHBA and fHbp. CONCLUSIONS: 4CMenB has the potential to protect against a significant proportion of Greek invasive MenB strains.
Cited literature [35 references]
https://hal-pasteur.archives-ouvertes.fr/pasteur-00990250
Contributor : Ed. Bmc <>
Submitted on : Tuesday, May 13, 2014 - 1:05:50 PM
Last modification on : Monday, January 13, 2020 - 5:08:15 PM
Long-term archiving on: : Monday, April 10, 2017 - 9:59:03 PM
Contributor : Ed. Bmc <>
Submitted on : Tuesday, May 13, 2014 - 1:05:50 PM
Last modification on : Monday, January 13, 2020 - 5:08:15 PM
Long-term archiving on: : Monday, April 10, 2017 - 9:59:03 PM